On to the next round… semi-finalists named in Cambridge Enterprise business plan competition
Cambridge Enterprise is delighted to announce that nine semi-finalist projects have been selected in the 2016 Entrepreneurial Postdocs of Cambridge (EPOC) business plan competition.
Spin-out Breathing Buildings develops natural building ventilation technology
A Cambridge spin-out has developed a completely new way of ventilating buildings that has the potential to reduce heating bills by as much as 50 percent while drastically reducing energy consumption. The natural ventilation technology concept exploits the heat produced by people, lights, IT and even sunlight, avoiding the wasteful use of radiators.
Cambridge spin-out secures £700K to develop smart infrastructure, sensors and IoT
8power Limited, a new company spun-out of the University of Cambridge to develop and commercialise novel technology for sensing and measurement in industrial applications, has received initial funding of approximately £700,000 from IP Group plc (LSE: IPO), the University of Cambridge and the University of Cambridge Enterprise Fund III, managed by Parkwalk Advisors.
Cambridge battery paste recycling technology is licensed to Aurelius Environmental
A lead-acid battery paste recycling technology that is cheaper and cleaner than traditional methods, developed by Dr RV Kumar and his research team of the Materials Science Department at the University of Cambridge, has been licensed to Aurelius Environmental (AE) in the West Midlands.
Cambridge University and GSK partner to discover and develop novel HIV therapeutics
A new collaboration between University of Cambridge researchers and global pharmaceutical company GlaxoSmithKline (GSK) has been established to discover and develop new medicines to treat HIV.
Cambridge CMOS Sensors acquired by ams to become world leader in gas and infrared sensing
Austria-based ams, a leading worldwide manufacturer of high performance sensor and analog solutions, has signed an agreement to acquire 100% of the shares in Cambridge CMOS Sensors Ltd (CCMOSS), the technology leader in micro hotplate structures for gas sensing and infrared applications, in an all-cash transaction.
Cambridge Enterprise film takes gold at the EVCOM Screen Awards
The Cambridge Enterprise film, #nextgreatidea, was awarded gold at the EVCOM Screen Awards 2016, held at Lindley Hall in Westminster.
Dr Richard Butt appointed CEO of Apollo Therapeutics
Apollo Therapeutics, the investment fund focused on driving therapeutic innovation through university collaboration, has appointed Dr Richard Butt as CEO, effective from 23 May 2016.
ROADMap Systems secures $1.7m in Series A investment
ROADMap has announced that it has successfully closed a funding round of $1.7 million by securing investment from a number of institutional and private investors. The round was led by Cambridge Enterprise, the commercialisation arm of the University of Cambridge, which also led the earlier funding rounds. The investment will help fund the expansion of the business as it takes its revolutionary…
Cambridge Enterprise film shortlisted for leading corporate film award
The Cambridge Enterprise film, #nextgreatidea, launched in November 2015 to showcase some of the world-changing ideas it has supported in the journey to market, has been nominated in the 'Brand Communication' category at the EVCOM Screen Awards 2016.
Quethera awarded Wellcome Trust Pathfinder grant
Quethera Ltd, a privately funded gene therapy company based at the Babraham Research Campus in Cambridge, has obtained a grant from the Wellcome Trust Pathfinder Award Scheme. Quethera was founded in 2013 to treat glaucoma using gene therapy. It received seed funding last year from the Rainbow Seed Fund and Cambridge Enterprise, the commercialisation arm of the University of Cambridge.
Cambridge spin-out secures $3m to improve oil recovery efficiency
Silicon MicroGravity (SMG), a newly-formed University of Cambridge spin-out that has developed a novel sensor technology used by oil companies to enhance oil recovery, has received initial funding of $3 million from Imperial Innovations Group plc and Cambridge Enterprise, the commercialisation arm of the University of Cambridge, together with grant funding from the UK government.
The University of Cambridge Enterprise Fund IV is launched
The University of Cambridge Enterprise Fund IV has been launched by Parkwalk Advisors, a London-based independent investment management firm, in conjunction with Cambridge Enterprise.
Start-up developing next-gen 3D touch technology secures investment
Cambridge Touch Technologies Ltd CTT), a University of Cambridge start-up poised to make 3D touch technology a standard feature on smart devices, has received seed investment by Cambridge Enterprise, the commercialisation arm of the University.
University of Cambridge breaks its early stage investment record for third consecutive year
For the third consecutive year, the University of Cambridge has broken its early stage investment record, approving 13 seed fund investments for a total of £3.8 million, an increase on the £3.2 million invested in 2013-14.
Cambridge joins consortium to launch £40 million Apollo fund to drive therapeutic innovation
Three global pharmaceutical companies (AstraZeneca, GlaxoSmithKline, Johnson & Johnson Innovation) and the technology transfer offices of three world-leading universities (Imperial College London, University College London and the University of Cambridge) have joined forces with a combined £40 million to create the Apollo Therapeutics Fund (Apollo).
Immaterial wins first prize in postdoc business plan competition
Andrew Marsden, of Cambridge University’s Department of Chemistry, last week accepted first prize on behalf of his team for Immaterial in the first-ever postdoc business plan competition, run by Cambridge Enterprise (CE) and the Entrepreneurial Postdocs of Cambridge (EPOC).
CE partners with Ximbio to make life science research tools more widely available
Cambridge Enterprise has partnered with Ximbio, the research tools business unit of Cancer Research Technology; itself the commercialisation division of Cancer Research UK, to make the University’s life science research tools more widely available to the worldwide scientific community
New Cambridge Enterprise film captures six revolutionary ideas in 90 seconds
Cambridge Enterprise, the commercialisation arm of the University of Cambridge, has launched a new film about its work.
Cytora receives investment led by the University of Cambridge
Cytora, a pioneer in event detection, whose risk analytics technology is deployed in some of the largest companies and governments in the world, has raised its second round of investment.
New study shows artificial pancreas works for length of entire school term
An artificial pancreas given to children and adults with type 1 diabetes going about their daily lives has been proven to work for 12 weeks – meaning the technology, developed at the University of Cambridge, can now offer a whole school term of extra freedom for children with the condition.
Lumora acquired by ERBA Diagnostics Mannheim
ERBA Diagnostics Mannheim GmbH, a global in vitro diagnostics company, today announced it has completed the acquisition of Lumora, a provider of state-of-the-art molecular diagnostic products for the clinical and industrial markets. Financial terms were not disclosed.
Collagen Solutions acquires assets for ChondroMimetic and related products
Collagen Solutions plc, the developer and manufacturer of medical grade collagen components for use in regenerative medicine, medical devices and in-vitro diagnostics, has acquired all of the assets and an exclusive worldwide licence for the associated intellectual property to ChondroMimetic from Orthomimetics Limited (OL) and Cambridge Enterprise (CE), the commercialisation arm of the University…
Jukedeck named one of WIRED’s ‘100 Hottest European Startups’ of 2015
Jukedeck, a University start-up and Cambridge Enterprise portfolio company, has been named one of WIRED’s ‘100 Hottest European Startups’ in 2015.
Postdoc business plan competition open for entries
Cambridge Enterprise and the Entrepreneurial Postdocs of Cambridge (EPOC) have launched a new business plan competition aimed at helping University of Cambridge postdocs successfully commercialise their ideas.